XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 31 filers reported holding XENON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,145,623 | -27.4% | 121,359 | -67.5% | 0.76% | +57.6% |
| Q3 2021 | $5,707,000 | -88.9% | 373,510 | +35.3% | 0.48% | -86.2% |
| Q2 2021 | $51,412,000 | +848.2% | 276,130 | -48.3% | 3.48% | +602.4% |
| Q1 2019 | $5,422,000 | +91.2% | 533,655 | +18.7% | 0.50% | +54.7% |
| Q4 2018 | $2,836,000 | -43.4% | 449,484 | +18.4% | 0.32% | -44.3% |
| Q3 2018 | $5,009,000 | +24.0% | 379,484 | -13.6% | 0.58% | +3.2% |
| Q2 2018 | $4,039,000 | +500.1% | 439,034 | +92.5% | 0.56% | +480.2% |
| Q3 2017 | $673,000 | -6.3% | 228,029 | 0.0% | 0.10% | -21.3% |
| Q2 2017 | $718,000 | -45.3% | 228,029 | -30.5% | 0.12% | -52.3% |
| Q1 2017 | $1,312,000 | -48.1% | 328,029 | 0.0% | 0.26% | -59.9% |
| Q4 2016 | $2,526,000 | +36.8% | 328,029 | +43.9% | 0.64% | +112.3% |
| Q3 2016 | $1,847,000 | – | 228,029 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |